Medicare Part D plans significantly increased restrictions on prescription drugs, excluding more compounds from coverage or subjecting more of them to review before patients could access the treatments, according to a new ...
Mar 4, 2024
0
2
Researchers from Johns Hopkins University published a new Journal of Marketing article that examines how receiving negative medical results might affect how people choose between generic and brand name drugs.
Apr 19, 2023
0
4
India's Patent Office rejected on Thursday US pharmaceutical giant Johnson and Johnson's application to extend its patent on a key tuberculosis treatment, allowing local companies to make cheaper generic versions.
Mar 23, 2023
0
3
An early surge in cold and flu cases has created shortages in key antiviral and antibiotic drugs needed for the annual "sick season," pharmacists report.
Nov 30, 2022
0
2
For years, brand drug companies have been villainized for "evergreening" or manipulating the law to extend the period of exclusivity for drugs beyond their 20-year patent—a practice critics say unfairly prevents competition ...
Nov 3, 2022
0
4
Unequal distribution of COVID-19 antivirals means patients are buying pills online that may not be safe when taken without medical supervision, finds an investigation published by The BMJ today.
May 31, 2022
0
26
Families across the U.S. are scrambling to feed their babies as formula becomes less and less available.
May 11, 2022
0
4
The Medicare Part D program would have saved $977 million in a single year if all branded prescription drugs requested by prescribing clinicians had been substituted by a generic option, according to a new study by researchers ...
Mar 2, 2021
1
1
The cost of prescriptions for multiple sclerosis (MS) drugs nearly tripled over seven years, and the introduction of a generic version of one of the most common drugs had little overall effect on prices, according to a study ...
Jan 15, 2020
0
1
Discount cards for brand-name drugs provided to patients increased private insurer costs by 46% and varied in their impact on out-of-pocket payments by patients, found new research in CMAJ (Canadian Medical Association Journal).
Nov 11, 2019
0
1
